INTRODUCTION
Osmotic demyelination syndrome (ODS), an acquired demyelinating disease of the central pons, was first described in 1959
by Adams et al. (1) in hyponatremic alcoholics. This disorder was formerly known as central pontine myelinolysis, extrapontine myelinolysis, or a combination of both (2). ODS has been classically defined as a symmetrical and selective destruction of myelin sheaths in the central portion of the basis pontis that typically occurs after rapid correction of hyponatremia (1, 3) .
However, ODS may develop in other medical conditions such as electrolyte imbalance, syndrome of inappropriate antidiuretic syndrome (SIADH), chronic renal failure, organ transplantation, and chemotherapy (3). Patients typically have various symptoms, ranging from mild neurologic symptoms to a complete locked-in syndrome, coma, or death (1) (2) (3) . In this paper, we describe a case of ODS in a patient with normonatremia who recently received chemotherapy for colon cancer. We also performed relevant literature review on this disease.
CASE REPORT
A 66-year-old man presented to our hospital with a 1 month history of intermittent headache. There was no prior history of any neurological disorder. He underwent low anterior resection for colon cancer and adjuvant chemotherapy 5 years ago. One month ago, he received a palliative chemotherapy with 5-fluorouracil, oxaliplatin and leucovorin. After starting the chemotherapy, he had intermittent headaches in the right temporal area.
Although he received medical treatment for tension headache, Osmotic demyelination syndrome (ODS), an acquired demyelinating condition of the central pons and/or other regions of the brain, is frequently associated with rapid correction of hyponatremia. There are several reports of ODS in other clinical setting such as malnutrition, alcoholism, transplantation, malignancy, and chronic debilitating illness. However, cases of ODS associated with chemotherapy have not been frequently reported. Here, we describe a case of ODS in a normonatremic patient recently underwent chemotherapy for colon cancer. The diagnosis was confirmed by MRI showing a typical T2 hyperintensity in the central pons. This case suggests that ODS is not always associated with hyponatremia and that ODS can have a favorable clinical and radiologic prognosis. Moreover, a 2-month follow-up brain MR imaging with gadolinium showed a complete resolution of the preexisting pontine lesion (Fig. 1E, F) . Therefore, the patient was diagnosed as ODS.
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DISCUSSION
ODS is an uncommon demyelinating disorder of unknown cause. Although there was no mention of electrolyte imbalance in the first description of ODS by Adams et al. (1) , ODS was there was no improvement for his headache. He had no other diseases such as chronic renal disease, hypertension, or diabetes mellitus. Physical examination and laboratory studies revealed no gross abnormalities. A careful neurological examination revealed no focal sign. Therefore, magnetic resonance (MR) imaging was performed to evaluate intracranial lesion. MR imaging showed T2 hyperintense lesion in the central pons without mass effect. This lesion revealed hypointensity on T1-weighted imaging without contrast enhancement. There were no other abnormalities in the rest of the brain (Fig. 1A-D) . The prepontine cistern and fourth ventricle were unaffected by this lesion. There was no evidence of electrolyte abnormalities (sodium at 137 On T1-weighted imaging, the lesion is hypointensity without enhancement after the administration of contrast material. Diffusion-weighted MR imaging is the most sensitive imaging modality which could detect the lesion within 24 hours of development of symptoms. The severity of the lesion is not correlated with the severity of symptoms. As clinical symptoms subside, the lesion will decrease in size and signal intensity on T2-weighted and fluid-attenuated inversion recovery imaging (8) .
In the present case, ODS occurred in a patient with normonatremia who received a palliative chemotherapy for colon cancer.
Our patient complained a nonspecific pattern of headache without neurologic deficits. We considered a list of differential diagnosis including infarction, focal pontine leukoencephalopathy, atypical posterior reversible encephalopathy syndrome, brainstem encephalitis, tumor; brainstem glioma or atypical metastasis, and multiple sclerosis. However, these were excluded in this case based on the unifocal nature of the lesion, sparing of the peripheral pons, the lack of mass effect, the lack of significant
